tazemetostat April 12, 2017 tazemetostat Trade Name Orphan Indication Malignant rhabdoid tumors (MRTs) USA Market Approval USA USA Designation Date 2016-02-04 00:00:00 Sponsor Epizyme Inc.;400 Technology Square, 4th Floor;Cambridge, Massachusetts, 02139
